How much is ergomed worth?
It has a market capitalisation of £543 m, with approximately 49 m shares in issue. Over the last year, Ergomed share price has been traded in a range of 550, hitting a high of 1585, and a low of 1035. Miroslav Reljanovic held the position of Executive Chairman at the time of this trade.
How do I buy shares in ergomed plc (ergo)?
To buy shares in Ergomed plc (LON:ERGO), you'll need to have an account. Try our handy filter to explore the different options. Ready to invest in Ergomed plc (ERGO)? To invest in Ergomed plc (LON:ERGO), you'll need to open an account. Try our handy filter to find which one suits you best.
What is ergomed's market cap?
It has a market capitalisation of £543 m, with approximately 49 m shares in issue. Over the last year, Ergomed share price has been traded in a range of 550, hitting a high of 1585, and a low of 1035.
What is ergomed plc Ord 1p?
Ergomed is part of the Medicine and Biotech sector. Ergomed Plc Ord 1P is listed on the London Stock Exchange, trading with ticker code ERGO. It has a market capitalisation of £543 m, with approximately 49 m shares in issue. Over the last year, Ergomed share price has been traded in a range of 550, hitting a high of 1585, and a low of 1035.
How has Ergomed's stock price performed in 2022?
Ergomed's stock was trading at GBX 1,500 at the start of the year. Since then, ERGO stock has decreased by 30.5% and is now trading at GBX 1,042....
How were Ergomed's earnings last quarter?
Ergomed plc (LON:ERGO) announced its earnings results on Monday, September, 18th. The company reported $1.20 earnings per share for the quarter. Th...
Who are Ergomed's key executives?
Ergomed's management team includes the following people: Dr. Miroslav Reljanovic , Founder & Exec. Chairman (Age 63, Pay $353.89k) Mr. Richard T...
Who are some of Ergomed's key competitors?
Some companies that are related to Ergomed include Genus (GNS) , Cronos Group (CRON) , Concordia International (CXR) , BELLUS Health (BLU) , B...
What other stocks do shareholders of Ergomed own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Ergomed investors own include Dicerna Pharmaceuticals (DRN...
What is Ergomed's stock symbol?
Ergomed trades on the London Stock Exchange (LON) under the ticker symbol "ERGO."
How do I buy shares of Ergomed?
Shares of ERGO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). So...
What is Ergomed's stock price today?
One share of ERGO stock can currently be purchased for approximately GBX 1,042.
How much money does Ergomed make?
Ergomed (LON:ERGO) has a market capitalization of £518.60 million and generates £118.58 million in revenue each year.
About Ergomed
Headlines
Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom and Rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Outsourcing and Pharmacovigilance.
Ergomed (LON:ERGO) Frequently Asked Questions
Ergomed plc's (LON:ERGO) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Ready to invest in Ergomed plc (ERGO)?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ergomed in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Ergomed stock. View analyst ratings for Ergomed or view top-rated stocks.
Broker forecasts
To invest in Ergomed plc (LON:ERGO), you'll need to open an account. Try our handy filter to find which one suits you best.
Download interim Report & Accounts
Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.
Transparency is our policy. Learn how it impacts everything we do
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset.
How we make money
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we use your personal data
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we approach editorial content
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
